411 REFERENCE · Wikibooks
Radiation Oncology/RTOG Trials/0319
Reference material by Wikibooks contributors. This retains its source identity and is not 411 news reporting.
RTOG 03-19 (Breast)
Title: A Phase I/II Trial to Evaluate 3D-CRT Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma
Objective:
Protocol:
38.5 Gy Total/10 fractions (3.85 Gy per fraction), 2 fractions/day (separated by 6 hours), Given in 5 consecutive working days
Radiotherapy should begin within eight weeks of surgery (If chemotherapy is given first, RT begins 2 weeks after the last cycle of chemotherapy)
Eligibility:
Invasive pathology; AJCC Stage I-II; single focus
Negative surgical margin; up to 3 LN+
Enrollment Target: 46 patients
Activation: August 15, 2003
Closed: April 30, 2004